Position in CGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,642
-$7,438 QoQ
Shares Held
1,702
-67.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 82 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Steward Partners Investment Advisory, LLC holds $58,578,486 across 161 Biotechnology names. CGEN ranks #112 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
351,178 | $13,699,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,851 | $10,357,317 | |
| 3 | ARGX |
Argenx SE
|
9,982 | $9,261,000 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,148 | $3,209,983 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
55,012 | $3,147,786 | |
| 6 | CRMD |
CorMedix Inc.
|
232,615 | $1,826,027 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
165,142 | $1,621,694 | |
| 8 | NKTR |
Nektar Therapeutics
|
18,279 | $1,276,056 |
All Filings in CGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,642 | 1,702 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $11,080 | 5,202 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $7,959 | 5,202 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,646 | 5,202 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,259 | 5,202 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,594 | 5,202 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,959 | 5,202 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $9,415 | 5,202 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,739 | 5,202 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $9,030 | 3,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,930 | 3,500 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,255 | 3,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,990 | 3,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,450 | 3,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,520 | 3,500 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,310 | 3,500 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,475 | 3,500 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $11,270 | 3,500 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $15,050 | 3,500 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $20,895 | 3,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $28,980 | 3,500 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $30,065 | 3,500 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $42,385 | 3,500 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $56,875 | 3,500 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $60,080 | 4,000 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $29,040 | 4,000 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||